{"DataElement":{"publicId":"64787","version":"3","preferredName":"Histologic Nottingham Score Tubulin Formation Type","preferredDefinition":"a weighted value describing a percentage of microtubules forming in tumor cells at time of microscopic assessment using the Nottingham Prognostic Index for grade of breast cancer.","longName":"HIST_NS_TUB_FORM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010838","version":"3","preferredName":"Histologic Nottingham Score Tubulin Formation","preferredDefinition":"related to the outcome of assessment of the microscopic forming of microtubules in tumor cells as part of criteria from the Nottingham Prognostic Index to determine the grade of breast cancer.","longName":"HIST_NS_TUB_FORM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2494661","version":"1","preferredName":"Histologic Nottingham Score","preferredDefinition":"Of or relating to histology.:The numerical result of analysis of a breast cancer based on the Nottingham Prognostic Index.","longName":"C25526:C25595","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EEBCA2-7C1C-2B27-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2494663","version":"1","preferredName":"Tubulin Formation","preferredDefinition":"Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulin. The genes encoding these microtubule constituents are part of the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes and they are highly conserved among and between species. (from LocusLink):Formation; the act of forming something.","longName":"C17219:C25513","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tubulin","conceptCode":"C17219","definition":"Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulin. The genes encoding these microtubule constituents are part of the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes and they are highly conserved among and between species. (from LocusLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Formation","conceptCode":"C25513","definition":"The act of forming something or the structure formed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EEBCA2-7C2E-2B27-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EBD364-202C-3E9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015542","version":"3","preferredName":"Histologic Nottingham Score Tubulin Formation Type","preferredDefinition":"a weighted value describing a percentage of microtubules forming in tumor cells at time of microscopic assessment using the Nottingham Prognostic Index for grade of breast cancer.","longName":"HIST_NS_TUB_FORM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17EC2AED-8F62-2585-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":"Majority of tumor, >75%","valueDescription":"MAJORITY OF TUMOR, >75% (1 PT)","ValueMeaning":{"publicId":"2559145","version":"1","preferredName":"MAJORITY OF TUMOR, >75% (1 PT)","longName":"2559145","preferredDefinition":"MAJORITY OF TUMOR, >75% (1 PT)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B416-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17EC2AED-8F6C-2585-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":"Minimal, <10%","valueDescription":"MINIMAL, < 10% (3 PT)","ValueMeaning":{"publicId":"2559247","version":"1","preferredName":"MINIMAL, < 10% (3 PT)","longName":"2559247","preferredDefinition":"MINIMAL, < 10% (3 PT)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B47C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17EC2AED-8F76-2585-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"PWEST","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":"Moderate, 10% to 75%","valueDescription":"MODERATE, 10% TO 75 % (2 PT)","ValueMeaning":{"publicId":"2559268","version":"1","preferredName":"MODERATE, 10% TO 75 % (2 PT)","longName":"2559268","preferredDefinition":"MODERATE, 10% TO 75 % (2 PT)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B491-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17EC2AED-8F80-2585-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"PWEST","dateModified":"2006-07-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EC2AED-8F4E-2585-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"REEVESD","dateModified":"2012-10-12","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Value List from CAP","type":"DATA_ELEMENT_SOURCE","description":"College of American Pathology; Protocol for Breast Cancer; revision date: January 2005; based on Fitzgibbons, et al. Arch Pathol Lab Med. 2000 Jul;124(7):966-78.","url":null,"context":"CTEP"},{"name":"Tubule Formation","type":"Preferred Question Text","description":"Tubule Formation","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EC28F9-8140-1DD9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"LUY","dateModified":"2013-10-23","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}